EA
INSM icon

Emerald Acquisition’s Insmed INSM Stock Holding History

Emerald Acquisition’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$121K Buy
+8,357
New +$105K ﹤0.01% 2783

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Acquisition's INSM Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Insmed (INSM) in Q3 2016: 8,357 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #2783 among its holdings.

98 funds tracked by Wall St. Rank hold INSM as of Q3 2016.

  • Emerald Acquisition held 8,357 shares of Insmed worth $121K as of Q3 2016.
  • Insmed was a new Emerald Acquisition position in Q3 2016.
  • Insmed made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2783 holding.
  • 98 funds tracked by Wall St. Rank held Insmed as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.